戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y factor for protection against cerebral and ocular toxoplasmosis.
2 s and might contribute to the development of ocular toxoplasmosis.
3 lls plays a central role in the pathology of ocular toxoplasmosis.
4 sefulness of blood samples for genotyping in ocular toxoplasmosis.
5 directly from blood samples of patients with ocular toxoplasmosis.
6  the regulation of inflammation during acute ocular toxoplasmosis.
7 he epidemiology and efficacious treatment of ocular toxoplasmosis.
8 likely to be involved in the pathogenesis of ocular toxoplasmosis.
9 NA sequence in samples from 12 patients with ocular toxoplasmosis, 1 sample from a patient with conge
10 urrence of certain forms of uveitis (such as ocular toxoplasmosis) after surgery, suggesting that per
11                The subsequent diagnoses were ocular toxoplasmosis and cytomegalovirus retinitis.
12 med in 46 serum specimens from patients with ocular toxoplasmosis and in 28 serum specimens from pati
13 lf from CD4 T-cell-mediated immune damage in ocular toxoplasmosis and other types of retinal immune r
14 nse of 59 cases of POT and 4 cases of active ocular toxoplasmosis (AOT).
15 s determining the pathogenesis and course of ocular toxoplasmosis are poorly understood.
16                          Recurrence rates of ocular toxoplasmosis are probably not higher during preg
17 matopoietic cells and can cause cerebral and ocular toxoplasmosis, as a result of either congenital o
18 otide sequences from Colombian patients with ocular toxoplasmosis belonged to the group of mouse-viru
19 n of 12 sequences (83.3%) from patients with ocular toxoplasmosis clustered with those of mouse-virul
20                   There were 128 episodes of ocular toxoplasmosis during the study period (6 during p
21                   Twenty patients (17%) with ocular toxoplasmosis had a localized RNFL defect associa
22 retinochoroiditis is a major complication of ocular toxoplasmosis in infants and immunocompetent indi
23  is involved in the pathogenesis of acquired ocular toxoplasmosis in mice.
24 n determining susceptibility to experimental ocular toxoplasmosis in murine models.
25 sL interaction in a murine model of acquired ocular toxoplasmosis induced by intracameral inoculation
26                                              Ocular toxoplasmosis is a potentially blinding intraocul
27                                              Ocular toxoplasmosis is a prominent and severe condition
28                             The diagnosis of ocular toxoplasmosis is based most often on the presence
29 ents with both typical and atypical forms of ocular toxoplasmosis may be good.
30 s of patients with Behcet uveitis (n = 259), ocular toxoplasmosis (n = 120), and multiple sclerosis (
31                            First episodes of ocular toxoplasmosis occurred between ages 9.6 and 38.5
32                                   Worldwide, ocular toxoplasmosis (OT) is the principal cause of post
33 us fluid of patients with severe or atypical ocular toxoplasmosis, polymerase chain reaction (PCR) re
34 ibships and 89 parent/case trios of presumed ocular toxoplasmosis (POT) to evaluate associations with
35     We tested all samples from patients with ocular toxoplasmosis sent to the Palo Alto Medical Found
36 ole of CD4(+) T cells in the pathogenesis of ocular toxoplasmosis was investigated in murine models u
37     In a prospective clinical study of acute ocular toxoplasmosis, we assessed the cytokine pattern i
38 rstand the role of interleukin-10 (IL-10) in ocular toxoplasmosis, we compared C57BL/6 (B6) and BALB/
39           Although in the past most cases of ocular toxoplasmosis were considered to result from reac
40 on regarding all pregnancies and episodes of ocular toxoplasmosis, whether or not episodes were obser
41 nged to type I, suggesting an association of ocular toxoplasmosis with this type.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。